UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
telaprevir (609) 609
science & technology (373) 373
life sciences & biomedicine (367) 367
humans (333) 333
boceprevir (309) 309
hepatitis c (290) 290
hepatitis c virus (240) 240
hepatitis c, chronic - drug therapy (225) 225
antiviral agents - therapeutic use (220) 220
ribavirin (190) 190
gastroenterology & hepatology (170) 170
oligopeptides - therapeutic use (169) 169
drug therapy, combination (168) 168
male (164) 164
female (154) 154
middle aged (153) 153
hepacivirus - genetics (146) 146
ribavirin - therapeutic use (137) 137
treatment outcome (129) 129
protease inhibitors (128) 128
interferon (127) 127
interferon-alpha - therapeutic use (121) 121
genotype (118) 118
antiviral agents - adverse effects (116) 116
proline - analogs & derivatives (107) 107
adult (106) 106
hepacivirus - drug effects (104) 104
infectious diseases (104) 104
aged (97) 97
oligopeptides - adverse effects (96) 96
antiviral agents (95) 95
hepatitis c, chronic - virology (93) 93
polyethylene glycols - therapeutic use (93) 93
biological response modifiers (91) 91
chronic hepatitis c (91) 91
antiviral agents - administration & dosage (89) 89
hepatitis (86) 86
hepatitis c - drug therapy (81) 81
oligopeptides - administration & dosage (79) 79
proline - therapeutic use (78) 78
proteases (76) 76
pharmacology & pharmacy (74) 74
care and treatment (73) 73
health aspects (72) 72
drug therapy (71) 71
recombinant proteins - therapeutic use (70) 70
pegylated interferon (63) 63
hcv (62) 62
virology (58) 58
gastroenterology and hepatology (53) 53
ribavirin - administration & dosage (53) 53
genetic aspects (52) 52
biological and medical sciences (51) 51
medical sciences (51) 51
protease inhibitors - therapeutic use (51) 51
viral hepatitis (51) 51
simeprevir (49) 49
hiv (48) 48
analysis (45) 45
drug interactions (45) 45
viral diseases (45) 45
human viral diseases (44) 44
interferon-alpha - administration & dosage (44) 44
pharmacology. drug treatments (42) 42
rna, viral - blood (42) 42
virus diseases (42) 42
young adult (42) 42
ribavirin - adverse effects (41) 41
viral load (41) 41
medicine & public health (40) 40
liver cirrhosis (39) 39
sofosbuvir (39) 39
cirrhosis (37) 37
hepatology (37) 37
anemia (36) 36
liver (36) 36
polyethylene glycols - administration & dosage (36) 36
hepatitis c, chronic - genetics (34) 34
interferon-alpha - adverse effects (34) 34
hepatitis c - virology (33) 33
liver transplantation (33) 33
protease inhibitor (33) 33
time factors (33) 33
antibiotics. antiinfectious agents. antiparasitic agents (32) 32
drug therapy, combination - methods (32) 32
hepatitis c, chronic - complications (32) 32
peginterferon (32) 32
proline - administration & dosage (32) 32
antiviral therapy (31) 31
clinical trials as topic (31) 31
recombinant proteins - administration & dosage (31) 31
general & internal medicine (30) 30
medicine, general & internal (30) 30
prospective studies (30) 30
interleukins - genetics (29) 29
retrospective studies (29) 29
antiviral agents - pharmacology (28) 28
proline - adverse effects (28) 28
sustained virological response (28) 28
hepacivirus - isolation & purification (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (542) 542
Spanish (28) 28
Japanese (19) 19
German (15) 15
Hungarian (12) 12
Portuguese (10) 10
French (7) 7
Russian (7) 7
Czech (5) 5
Chinese (3) 3
Turkish (3) 3
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of basic and clinical physiology and pharmacology, ISSN 0792-6855, 11/2019, Volume 30, Issue 6
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 12/2014, Volume 59, Issue 12, pp. 1777 - 1778
Journal Article
Journal of hepatology, ISSN 0168-8278, 2013, Volume 59, Issue 3, pp. 434 - 441
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2405 - 2416
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Interferon-alpha - therapeutic use | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2b | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Fees & charges | Antiretroviral drugs | Liver diseases | Clinical trials | Chronic infection | Employees | Infections | Proteinase inhibitors | Genomes | Ribonucleic acid--RNA | Patients | Ribavirin | Liver cancer | Genotype & phenotype | Hepatitis | Skin | Interferon | Genotypes | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 25, pp. 2417 - 2428
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recurrence | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Young Adult | Serine Proteinase Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Logistic Models | Hepatitis C, Chronic - drug therapy | Sequence Analysis, DNA | Retreatment | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Aged | Interferon-alpha - adverse effects | Peginterferon alfa-2a | Patient outcomes | Genetic aspects | Hepatitis C | Drug therapy | Comparative analysis | Health aspects | Liver diseases | Cytokines | Leukopenia | Anemia | Infections | Ribonucleic acid--RNA | Ribavirin | Manuscripts | Genotype & phenotype | Consent | Interferon | Drug dosages | Genotypes | Neutropenia | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
World journal of hepatology, ISSN 1948-5182, 2016, Volume 8, Issue 22, pp. 949 - 956
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2014, Volume 147, Issue 1, pp. 132 - 142.e4
Journal Article
Journal of hepatology, ISSN 0168-8278, 2011, Volume 56, Issue 1, pp. 78 - 84
Journal Article